A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (TREASURE-CKD)
Phase 1
- Conditions
- T2D, Obesity, Overweight, Chronic Kidney Disease, CKD, Type 2 DiabetesTherapeutic area: Phenomena and Processes [G] - Metabolism [G03]
- Registration Number
- CTIS2023-506082-60-00
- Lead Sponsor
- Eli Lilly & Co.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Have obesity or overweight, Have chronic kidney disease, Half of participants must have type 2 diabetes and half of participants must not have type 2 diabetes
Exclusion Criteria
Have a history of diabetic eye diseases, Have gained weight within 90 days before study, Have a history of unstable or severe kidney disease
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method